Routine coagulation test abnormalities caused by rivaroxaban: A case report

RATIONALE: Rivaroxaban is a non-vitamin K antagonist oral anticoagulant. Current recommendations state that coagulation monitoring is not required, and neither the dose nor dosing interval requires adjustment in response to changes in coagulation parameters when rivaroxaban is used for approved indi...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Zikai, Wu, Haidi, Cao, Hongyan, Yang, Shuo, Tang, Minglong, Qin, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250517/
https://www.ncbi.nlm.nih.gov/pubmed/30407322
http://dx.doi.org/10.1097/MD.0000000000013104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250517/
https://www.ncbi.nlm.nih.gov/pubmed/30407322
http://dx.doi.org/10.1097/MD.0000000000013104

Ejemplares similares